(Q46039883)

18 December 2017

title

Synergistic inhibition effect of tumor growth by using celecoxib in combination with oxaliplatin. (English)

1 reference

18 December 2017

1 reference

Shipeng Zhao

1

1 reference

18 December 2017

Jianhui Cai

2

1 reference

18 December 2017

Honglei Bian

3

1 reference

18 December 2017

Lin Gui

4

1 reference

18 December 2017

Fa Zhao

5

1 reference

18 December 2017

publication date

1 July 2009

1 reference

18 December 2017

published in

Cancer Investigation

1 reference

18 December 2017

volume

27

1 reference

18 December 2017

issue

6

1 reference

18 December 2017

page(s)

636-640

1 reference

18 December 2017

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07357900802672738

COX-2 inhibition and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802672738

Convergence of Wnt, beta-catenin, and cadherin pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802672738

Survivin and molecular pathogenesis of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802672738

The Chemopreventive Agent Sulindac Attenuates Expression of the Antiapoptotic Protein Survivin in Colorectal Carcinoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802672738

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802672738

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802672738

10.1080/07357900802672738

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017